-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
M.
Through the mouse model, the researchers found that when Glatiramer acetate was used, the microglia (part of the brain's immune system) changed and cognitive behavior improved
“In general, these findings provide further evidence that therapies that modify the immune system can effectively treat Alzheimer’s disease.
Glatiramer acetate (Glatiramer acetate) is a synthetic peptide compound, developed and manufactured by the Israeli pharmaceutical company TEVA, under the trade name Copaxone®, which was approved by the US FDA for the treatment of multiple sclerosis in 1996.
Dawling A.